New media

Fortress Biotech to Participate in Three March 2022 Investor Conferences

Retrieved on: 
Wednesday, March 9, 2022

MIAMI, March 09, 2022 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (NASDAQ: FBIO) (Fortress), an innovative biopharmaceutical company focused on efficiently acquiring, developing and commercializing or monetizing promising therapeutic products and product candidates, today announced that Lindsay A. Rosenwald, M.D., Chairman, President and Chief Executive Officer, will participate in three investor conferences in March 2022.

Key Points: 
  • MIAMI, March 09, 2022 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (NASDAQ: FBIO) (Fortress), an innovative biopharmaceutical company focused on efficiently acquiring, developing and commercializing or monetizing promising therapeutic products and product candidates, today announced that Lindsay A. Rosenwald, M.D., Chairman, President and Chief Executive Officer, will participate in three investor conferences in March 2022.
  • Oppenheimers 32nd Annual Virtual Healthcare Conference: The company will present on Wednesday, March 16, 2022, at 8:40 a.m.
  • Cantor Fitzgeralds Rare Orphan Disease Summit: The company will participate in a panel presentation on Wednesday, March 30, 2022, at 8:30 a.m.
  • Fortress Biotech, Inc. (Fortress) is an innovative biopharmaceutical company focused on acquiring, developing and commercializing high-potential marketed and development-stage drugs and drug candidates.

Sinclair Broadcast Group Names Rob Weisbord Chief Operating Officer and President of Broadcast

Retrieved on: 
Wednesday, February 23, 2022

Sinclair Broadcast Group, Inc. (Nasdaq: SBGI) today announced Rob Weisbord has been elevated to Chief Operating Officer of the corporation and President of Broadcast.

Key Points: 
  • Sinclair Broadcast Group, Inc. (Nasdaq: SBGI) today announced Rob Weisbord has been elevated to Chief Operating Officer of the corporation and President of Broadcast.
  • Weisbord, who has served as the companys President of Broadcast and Chief Advertising Revenue Officer since 2020, will continue to report to Chris Ripley, President and Chief Executive Officer.
  • Since joining Sinclair in 1997, Weisbord has served in various executive management positions for the Company including Chief Operating Officer of Sinclair Digital Group, Vice President of New Media, Director of Digital Interactive Marketing, Regional Group Manager, and General Manager for the Companys Las Vegas duopoly of KVMY-TV and KVCW-TV.
  • Sinclair Broadcast Group, Inc. is a diversified media company and a leading provider of local sports and news.

Fortress Biotech to Participate in the H.C. Wainwright BioConnect Virtual Conference

Retrieved on: 
Thursday, January 6, 2022

Fortress Biotech, Inc. (Fortress) is an innovative biopharmaceutical company focused on acquiring, developing and commercializing high-potential marketed and development-stage drugs and drug candidates.

Key Points: 
  • Fortress Biotech, Inc. (Fortress) is an innovative biopharmaceutical company focused on acquiring, developing and commercializing high-potential marketed and development-stage drugs and drug candidates.
  • The company has seven marketed prescription pharmaceutical products and over 30 programs in development at Fortress, at its majority-owned and majority-controlled partners and at partners it founded and in which it holds significant minority ownership positions.
  • Such product candidates span six large-market areas, including oncology, rare diseases and gene therapy, which allow it to create value for shareholders.
  • Fortress advances its diversified pipeline through a streamlined operating structure that fosters efficient drug development.

PharmaCyte Biotech to Present at H.C. Wainwright BioConnect Conference

Retrieved on: 
Thursday, January 6, 2022

PharmaCyte Biotech, Inc. (NASDAQ: PMCB), a biotechnology company focused on developing cellular therapies for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box, today announced that it will be featured as a presenting company at the H.C. Wainwright BioConnect Conference.

Key Points: 
  • PharmaCyte Biotech, Inc. (NASDAQ: PMCB), a biotechnology company focused on developing cellular therapies for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box, today announced that it will be featured as a presenting company at the H.C. Wainwright BioConnect Conference.
  • During the presentation, the Chief Executive Officer of PharmaCyte Biotech, Kenneth L. Waggoner, will provide an overview of the Company's business and product pipeline.
  • The pre-recorded presentation by PharmaCyte will be available on Monday, January 10, 2022, on the News & Media tab of PharmaCytes website at https://PharmaCyte.com/Media .
  • PharmaCyte Biotech, Inc. is a biotechnology company developing cellular therapies for cancer and diabetes based upon a proprietary cellulose-based live cell encapsulation technology known as Cell-in-a-Box.

Cellectar to Participate in Fireside Chat at the H.C. Wainwright Bioconnect Conference

Retrieved on: 
Tuesday, January 4, 2022

The fireside chat will be available on demand beginning at 7:00 am ET on January 10, 2022.

Key Points: 
  • The fireside chat will be available on demand beginning at 7:00 am ET on January 10, 2022.
  • The event also will be available on the News & Media section of the companys website.
  • Cellectar Biosciences is focused on the discovery and development of drugs for the treatment of cancer.
  • These forward-looking statements are made only as of the date hereof, and we disclaim any obligation to update any such forward-looking statements.

OWC Named As 2021 IBC Best of Show Award Honoree

Retrieved on: 
Tuesday, December 21, 2021

Declared after the IBC 2021, IBC is the world's most influential media, entertainment, and technology show.

Key Points: 
  • Declared after the IBC 2021, IBC is the world's most influential media, entertainment, and technology show.
  • The Jellyfish by OWC product family consists of Jellyfish Mobile : The first plug-and-play video workflow server that comes with a handle.
  • "We are honored to have The Jellyfish by OWC product lineup recognized with the IBC Best of Show TV Tech Award presented by IBC," said JJ Powell, Director of Demand Generation/Sales, OWC.
  • Other World Computing (OWC), founded in 1988, is dedicated to helping Mac and PC enthusiasts do more and reach higher.

Frontier Medicines to Present at the RBC Capital Markets Healthcare Private Company Virtual Conference

Retrieved on: 
Thursday, December 9, 2021

SOUTH SAN FRANCISCO, Calif., Dec. 09, 2021 (GLOBE NEWSWIRE) -- Frontier Medicines Corporation, a precision medicine company seeking to unlock the proteome to advance breakthroughs against otherwise undruggable disease-causing targets, today announced that Chris Varma, Ph.D., Frontiers co-founder, chairman, and CEO, will present a company overview at the RBC Capital Markets Healthcare Private Company Virtual Conference on Thursday, December 16, 2021 at 4:30 p.m.

Key Points: 
  • SOUTH SAN FRANCISCO, Calif., Dec. 09, 2021 (GLOBE NEWSWIRE) -- Frontier Medicines Corporation, a precision medicine company seeking to unlock the proteome to advance breakthroughs against otherwise undruggable disease-causing targets, today announced that Chris Varma, Ph.D., Frontiers co-founder, chairman, and CEO, will present a company overview at the RBC Capital Markets Healthcare Private Company Virtual Conference on Thursday, December 16, 2021 at 4:30 p.m.
  • A live audio webcast of the presentation will be available for access in the News & Media section of Frontiers website ( LINK ).
  • Frontier Medicines is a precision medicine company that has pioneered a powerful discovery and development platform designed to generate medicines against disease-causing proteins previously considered undruggable.
  • Frontier is advancing its wholly-owned pipeline of precision medicines against the most important drivers of cancer.

OWC Named As 2021 Cine Gear Expo Technical Award Honoree

Retrieved on: 
Wednesday, November 10, 2021

Declared after the 2021 Cine Gear Expo LA Expo, one of the world's most premier events for professionals engaged in the technology, entertainment, and digital media industry.

Key Points: 
  • Declared after the 2021 Cine Gear Expo LA Expo, one of the world's most premier events for professionals engaged in the technology, entertainment, and digital media industry.
  • The Cine Gear Expo Technical Awards program, owned and produced by the Cine Gear Expo, is an annual competition honoring outstanding innovation in the video industry.
  • The Jellyfish by OWC product family consists of:
    Jellyfish Mobile: The first plug-and-play video workflow server with a handle.
  • "We are honored to have The Jellyfish by OWC product lineup recognized with the Technical Award presented by Cine Gear Expo," said Gergana Angelova, VP Product & Customer Experience - Enterprise Storage Marketing, OWC.

Elev8 New Media Wins Media Relations Award for Consumer Products at the 57th Annual PRSA LA PRism Awards

Retrieved on: 
Tuesday, October 26, 2021

Elev8 New Media , a media and public relations firm specializing in securing media and press coverage for its client companies, earned the 2021 Media Relations, Consumer Products Award for The Alkaline Water Companys partnership with basketball Hall of Famer and entertainment icon Shaquille ONeal at the 57th annual Public Relations Society of America (PRSA) Los Angeles PRism awards.

Key Points: 
  • Elev8 New Media , a media and public relations firm specializing in securing media and press coverage for its client companies, earned the 2021 Media Relations, Consumer Products Award for The Alkaline Water Companys partnership with basketball Hall of Famer and entertainment icon Shaquille ONeal at the 57th annual Public Relations Society of America (PRSA) Los Angeles PRism awards.
  • The PRism Awards honor the best in strategic public relations and communications programs and tactical execution by PR professionals throughout greater Los Angeles.
  • This year's PRism Awards took place at the Annenberg Community Beach House in Santa Monica, California.
  • Elev8 New Media is a boutique media relations firm specializing in increasing awareness for companies through traditional and modern media.

Fortress Biotech to Participate in the Benzinga Healthcare Small Cap Conference

Retrieved on: 
Tuesday, September 28, 2021

NEW YORK, Sept. 28, 2021 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (NASDAQ: FBIO) (Fortress), an innovative biopharmaceutical company focused on acquiring, developing and commercializing or monetizing promising biopharmaceutical products and product candidates cost-effectively, today announced that Lindsay A. Rosenwald, M.D., Chairman, President and Chief Executive Officer, will participate in the Benzinga Healthcare Small Cap Conference, scheduled to take place from September 29-30, 2021.

Key Points: 
  • NEW YORK, Sept. 28, 2021 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (NASDAQ: FBIO) (Fortress), an innovative biopharmaceutical company focused on acquiring, developing and commercializing or monetizing promising biopharmaceutical products and product candidates cost-effectively, today announced that Lindsay A. Rosenwald, M.D., Chairman, President and Chief Executive Officer, will participate in the Benzinga Healthcare Small Cap Conference, scheduled to take place from September 29-30, 2021.
  • Details of the events are as follows:
    Presentation: The company will present a corporate update on Thursday, September 30, 2021, at 11:30 a.m.
  • ET and will participate in one-on-one meetings during the conference.
  • Panel: Dr. Rosenwald will also participate in a panel discussion entitled, Immuno-Oncology: Harnessing the Human Body's Power to Battle Cancer, on Thursday, September 30, 2021, at 12:35 p.m.